Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2013 Dec 2;123(12):5411. doi: 10.1172/JCI73904

ATP11B mediates platinum resistance in ovarian cancer

Myrthala Moreno-Smith, JB Halder, Paul S Meltzer, Tamas A Gonda, Lingegowda S Mangala, Rajesha Rupaimoole, Chunhua Lu, Archana S Nagaraja, Kshipra M Gharpure, Yu Kang, Cristian Rodriguez-Aguayo, Pablo E Vivas-Mejia, Behrouz Zand, Rosemarie Schmandt, Hua Wang, Robert R Langley, Nicholas B Jennings, Cristina Ivan, Jeremy E Coffin, Guillermo N Armaiz, Justin Bottsford-Miller, Sang Bae Kim, Margaret S Halleck, Mary JC Hendrix, William Bornman, Menashe Bar-Eli, Ju-Seog Lee, Zahid H Siddik, Gabriel Lopez-Berestein, Anil K Sood
PMCID: PMC3859397

Original citation: J Clin Invest. 2013;123(5):2119–2130. doi:10.1172/JCI65425.

Citation for this corrigendum: J Clin Invest. 2013;123(12):5411. doi:10.1172/JCI73904.

The legend for Figure 5 did not disclose that the images presented in part A were duplicated as the no treatment control for the cisplatin experiment shown in parts D and E. The authors wish to add the correction below to the legend for Figure 5.

The merged immunofluorescence images showing colocalization of ATP11B and STX6 in A2780-PAR and A2780-CP20 cells in A are shown again in D and E to demonstrate localization of ATP11B and STX6 in the absence of cisplatin in A2780-PAR and A2780-CP20 cells.

The authors regret the error.


Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES